药理学药剂针对炎症体的机制和治疗潜力
Haitao Li1, Tiantian Liu2, Xuezhen Shi3
1Department of Gastroenterology, 900th Hospital of PLA Joint Logistic Support Force, No. 156, West Second Ring Road, Fuzhou City 350025, China.
概括
最近的炎症酶研究显示,NEK7是NLRP3激活的关键标,并引入了新型抑制剂,如CY-09. 代谢重编程和向疗法对炎症性疾病有希望.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 炎症酶是炎症性疾病的关键调解者.
- 了解炎症体调节是开发向治疗的关键.
研究的目的:
- 为了突出最近在炎症研究中的突破.
- 为了确定新的治疗点和抑制策略的炎症状况.
主要方法:
- 确定NEK7是NLRP3炎症酶激活的重要组成部分.
- 开发CY-09,一种针对NLRP3.3的小分子抑制剂.
- 研究代谢重编程在炎症酶激活中的作用 (例如,itaconate).
- 在动脉样硬化中探索非正规的炎症酶途径.
- 纳米颗粒传递系统用于炎酶抑制的应用 (例如,AIM2).
主要成果:
- NEK7被确定为NLRP3炎症酶激活的关键标.
- CY-09显示了NLRP3.3的特定抑制.
- 伊塔科纳酸被发现直接抑制NLRP3激活,将新陈代谢和炎症联系起来.
- 在动脉样硬化进展中涉及的非正规性炎症体.
- 在临床前模型中,纳米粒子输送显示了AIM2炎症酶抑制在牛皮的有效性.
结论:
- 在了解炎症生物和调节方面取得了重大进展.
- 针对炎症体的创新治疗策略的出现.
- 对各种炎症性疾病进行更精确,更有效的治疗的潜力.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
204
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
204
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
240
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
240
The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
278
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
278
Inflammatory Response
8.5K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
8.5K
Inflammation
55.5K
Overview
55.5K


